Determination of gliclazide in a tablet dosage form in the presence of metformin hydrochloride by ion pair - Reversed phase liquid chromatographic technique

13Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

This study describes the development and validation of an isocratic HPLC method for the stability of gliclazide assay in the presence of metformin hydrochloride (MET) in pharmaceutical dosage forms using ion pair - reversed phase liquid chromatographic technique. The ion pairing agent used in this study is tetrabutyl ammonium hydrogen sulphate (TBHS). The TBHS 0.030 molar solution in water was adjusted to pH 6.0 with 1 N sodium hydroxide solution and was used as buffer. The composition of the buffer and acetonitrile used was 40:60 (v/v) on reverse phased column, bonded with octadecyl silane, while the wave length used was 225 nm. As such, the drug gave a linear response (r2>0.999). The method was found to be selective, precise, accurate and robust, and can be used for quality control assay of the bulk and finished dosage form as a single dose in combination with metformin hydrochloride. © 2011 Academic Journals.

Cite

CITATION STYLE

APA

Udaykumar Rao, B., & Nikalje, A. P. (2011). Determination of gliclazide in a tablet dosage form in the presence of metformin hydrochloride by ion pair - Reversed phase liquid chromatographic technique. African Journal of Pharmacy and Pharmacology, 5(11), 1331–1337. https://doi.org/10.5897/ajpp10.106

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free